RT Journal Article
SR Electronic
T1 Keratinocyte-derived VEGF biosynthesis represents a pleiotropic side effect of PPARγ agonist troglitazone but not rosiglitazone and involves activation of p38 MAPK: implications for diabetes-impaired skin repair
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
DO 10.1124/mol.108.049395
A1 Dana Schiefelbein
A1 Oliver Seitz
A1 Itamar Goren
A1 Jan Philipp DiBmann
A1 Helmut Schmidt
A1 Malte Bachmann
A1 Robert Sader
A1 Gerd Geisslinger
A1 Josef Pfeilschifter
A1 Stefan Frank
YR 2008
UL http://molpharm.aspetjournals.org/content/early/2008/07/03/mol.108.049395.abstract
AB